54 Waterloo Rd, North Ryde
Name: NOVARTIS AUSTRALIA PTY LIMITED
Address: 54 Waterloo Rd, North Ryde NSW 2113
Ph: +61 2 9805 3555
Novartis is caring and curing
Novartis is helping Australians live healthier lives. Our medicines focus on critical disease areas including cardiovascular and metabolic diseases, ophthalmology, neuroscience, respiratory diseases and oncology. Novartis’ history in Australia goes back over 50 years. Novartis is rated as one of the fastest growing pharmaceutical companies and in Australia we employ around 1,000 associates across our group.
Novartis is innovation
Novartis has pioneered some of the most innovative treatments to address unmet needs. These include treatments for macular degeneration, multiple sclerosis and cancer therapies which have helped improve the lives of Australians. Innovation is at the heart of Novartis and this drives our continued investment in R&D.
Novartis is investing
On average only one in 10,000 originally synthesised compounds will clear all regulatory hurdles and become a treatment option for patients. Despite this challenge, we believe continued investment is vital. Novartis is investing in Australian research and in 2012 we managed more than 160 clinical trials ranging from first-in-human and first-in-patient studies, through to key registration trials, at an investment of around AUD$ 30 million a year.
Novartis is people
Novartis is people. We are committed to creating the best place to work, attracting, retaining and motivating top talent in Australia and globally. We believe that keeping pace with our company’s rapid growth means investing in people as leaders of change – and this is vital on our journey to be the leading pharmaceutical companies in Australia.